Improving Statin Prescribing for People Living With HIV: A Quality Improvement Initiative.

Authors

Veronica Njuguna, John Hawkins, Navya Pothamsetty, Daniel Chen, Alyson Brinkman, Nirmala D Ramalingam, Christian Lee-Rodriguez, Mitchell N Luu

Published in

JACC. Case reports. Pages 109018. Jun 26, 2026. Epub Jun 26, 2026.

Abstract

People living with HIV (PLWH) have increased atherosclerotic cardiovascular disease risk. Guidelines recommend statin therapy for PLWH aged 40 to 75 years with a 10-year atherosclerotic cardiovascular disease risk of ≥5%.
Statin prescribing is suboptimal in this population. We implemented a quality improvement initiative to identify barriers and increase statin prescribing in eligible PLWH.
Seventeen of 25 (68%) Kaiser Permanente HIV specialists were surveyed on barriers to statin prescribing and participated in a quality improvement initiative that provided monthly education and prescribing feedback. Statin prescriptions among PLWH aged 40 to 75 years were assessed before the intervention (June-December 2024) and during the intervention (January-June 2025) using interrupted time series. Seventeen of 25 specialists (68%) participated. Reported barriers included patient reluctance (71%), nonautomated risk calculation (58%), and limited resources (47%). Baseline statin prescribing was 44.1%. Monthly prescribing increased from 0.30% preintervention to 1.24% postintervention (P < 0.001), yielding 193 additional prescriptions.
An intervention combining ongoing education with monthly performance feedback significantly improved statin prescribing rates among PLWH.

PMID:
42363931
Bibliographic data and abstract were imported from PubMed on 27 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.